
Kura Oncology Announces New Executive Compensation: Details on Inducement Grants under NASDAQ Rule 5635(c)4
Kura Oncology Announces Inducement Awards to Six New Employees On March 3, 2025, Kura Oncology, Inc. (the “Company”), a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment, made an important announcement regarding new hires and their compensation. The Company’s Compensation Committee, in accordance with Nasdaq Listing Rule 5635(c)(4), granted inducement awards to…